SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-20-006187
Filing Date
2020-11-02
Accepted
2020-11-02 12:00:11
Documents
3
Period of Report
2020-11-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm 8-K 15916
2 PRESS RELEASE ipix_ex991.htm EX-99.1 22148
3 PRESS RELEASE ipix_ex992.htm EX-99.2 15777
  Complete submission text file 0001477932-20-006187.txt   55119
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 201279590
SIC: 2834 Pharmaceutical Preparations